MEMBER'S LOGINX
| Login Failure | ||||||||
|
||||||||
| Sign Up | Forgot Password? | ||||||||
- Home
- Stock Quote
- BSE Healthcare
- Losers Today
Losers Today 
:
BSE Healthcare
Here are the top losers today from the BSE Healthcare index. To know more about the Index, please visit the BSE Healthcare Live Chart. Also read our detailed report on the pharmaceuticals sector.
Date: Dec 11, 2019 (Close)
| COMPANY | PRICE (Rs) | CHANGE (%) | VOLUME ('000) | DAY'S H/L (Rs) | 52-WEEK H/L (Rs) | GET MORE INFO |
|---|---|---|---|---|---|---|
| S&P BSE SENSEX | 40,412.57 | 0.4% | - |
40,466 / 40,135 |
41,164 / 35,011 |
More Info
|
| NIFTY 50 | 11,910.15 | 0.5% | - |
11,923 / 11,832 |
12,159 / 10,535 |
More Info
|
| S&P BSE HEALTHCARE | 13,278.74 | 0.4% | - |
13,293 / 13,206 |
14,594 / 11,874 |
More Info
|
| VIVIMED LABS | 10.85 | -9.0% | 59.6 | 12 / 10 | 41 / 10 | More Info
|
| NEULAND LABS | 396.65 | -5.7% | 3.4 | 422 / 391 | 825 / 391 | More Info
|
| HIKAL LTD. | 101.65 | -4.9% | 23.8 | 108 / 101 | 187 / 101 | More Info
|
| SUN PHARMA ADV. RES. | 162.95 | -4.2% | 107.6 | 171 / 160 | 217 / 107 | More Info
|
| HEALTHCARE GLOBAL ENTER. | 92.45 | -3.7% | 3.9 | 96 / 91 | 249 / 91 | More Info
|
| SEQUENT SCIENTIFIC | 64.10 | -3.7% | 45.9 | 66 / 64 | 89 / 62 | More Info
|
| CAPLIN POINT | 289.60 | -3.5% | 7.2 | 304 / 285 | 466 / 285 | More Info
|
| VIMTA LABS | 89.75 | -3.4% | 2.3 | 92 / 88 | 332 / 88 | More Info
|
| STRIDES PHARMA SCIENCE | 359.65 | -3.1% | 61.6 | 370 / 355 | 550 / 288 | More Info
|
| DISHMAN CARBOGEN AMCIS LTD | 119.95 | -2.5% | 8.1 | 124 / 117 | 258 / 110 | More Info
|
| PANACEA BIOTECH | 112.35 | -2.2% | 0.6 | 115 / 111 | 219 / 111 | More Info
|
| FDC LTD. | 201.80 | -2.1% | 1.1 | 211 / 201 | 220 / 148 | More Info
|
| INDRAPRASTHA MEDICAL | 37.55 | -2.0% | 5.8 | 38 / 38 | 47 / 34 | More Info
|
| AARTI DRUGS | 504.15 | -1.8% | 0.4 | 512 / 501 | 705 / 419 | More Info
|
| ERIS LIFESCIENCES LIMITED | 468.20 | -1.5% | 20.5 | 478 / 462 | 745 / 358 | More Info
|
| NECTAR LIFESCIENCE | 12.01 | -1.5% | 9.8 | 12 / 12 | 22 / 11 | More Info
|
| SHALBY LTD | 94.30 | -1.3% | 3.5 | 98 / 94 | 154 / 76 | More Info
|
| SYNGENE INTERNATIONAL | 300.00 | -1.3% | 0.9 | 309 / 299 | 368 / 261 | More Info
|
| NARAYANA HRUDAYALAYA LTD | 304.50 | -1.2% | 7.5 | 307 / 303 | 319 / 181 | More Info
|
| PROCTER & GAMBLE HEALTH | 4,133.45 | -1.1% | 0.2 | 4,223 / 4,120 | 5,121 / 2,818 | More Info
|
| LUPIN | 743.95 | -1.1% | 26.3 | 755 / 738 | 888 / 646 | More Info
|
| FORTIS HEALTHCARE | 135.00 | -1.0% | 16.5 | 137 / 135 | 161 / 112 | More Info
|
| J.B.CHEMICALS | 418.35 | -0.9% | 19.1 | 426 / 416 | 435 / 290 | More Info
|
| THYROCARE TECHNOLOGIES | 532.25 | -0.9% | 3.0 | 545 / 527 | 605 / 407 | More Info
|
| INDOCO REMEDIES | 149.40 | -0.8% | 0.4 | 152 / 148 | 232 / 133 | More Info
|
Circuit Breaker (up)
Circuit Breaker (down) * Mutual Funds that hold this stock
|
| |
Today's Market
Yes Bank's Fundraising Plan, Falling Crude Oil Prices, and Top Stocks in Action Today(Pre-Open)
On Wednesday, Indian share markets traded on a volatile note throughout the day and ended higher.
Related Views on News
MSTC IPO: Should You Bet on This State-Run E-Commerce Player? (IPO)
Mar 13, 2019Should you subscribe to the IPO of MSPC Limited?
Hindustan Aeronautics IPO: Yet Another Play on India's Defence Sector (IPO)
Mar 14, 2018Should you apply for the IPO of state-run military aircraft maker Hindustan Aeronautics?
Bharat Dynamics IPO: Worth Betting on Defence Manufacturing? (IPO)
Mar 12, 2018Should you apply for the IPO of Bharat Dynamics, India's first state-owned missile manufacturer?
Aster DM Healthcare (IPO)
Feb 10, 2018Should you subscribe to the IPO of Aster DM Healthcare Ltd?
Dr Reddy's: Milestone Payment Drives Sales (Quarterly Results Update - Detailed)
Feb 9, 2018US business was hit by pricing pressure although there was growth sequentially led by new product launches.
More Views on NewsMost Popular
Use My Secret to Increase Your Trading Profits Today
Dec 10, 2019What to do after every trade.
A Simple, 7-Step Checklist for Your Trading Success
Dec 4, 2019What we can learn from one of the greatest traders to have ever lived.
Blue Chips Are Passe. Get into these Stocks for Outstanding Gains in 2020 (Profit Hunter)
Dec 5, 2019This corner of the market could provide more returns than blue chips in 2020.
What Is the IPO Euphoria Signaling Us About the Markets? (The 5 Minute Wrapup)
Dec 2, 20192019 will be remembered as the year of great money-making IPOs...
Make the Most of the Smallcap Rebound with These Stocks (Profit Hunter)
Dec 3, 2019Even amid a gloomy economic scenario, there are smallcaps that have grown earnings over last one and a half year and I believe these could be the strongest candidates for a smallcap rebound.
MoreS&P BSE HEALTHCARE
Dec 11, 2019 (Close)
S&P BSE HEALTHCARE 5-YR ANALYSIS
COMPARE COMPANY
OTHER USEFUL LINKS
MARKET STATS
ABOUT EQUITYMASTER
Since 1996, Equitymaster has been the source for honest and credible opinions on investing in India. With solid research and in-depth analysis Equitymaster is dedicated towards making its readers- smarter, more confident and richer every day. Here's why hundreds of thousands of readers spread across more than 70 countries Trust Equitymaster.
FREE NEWSLETTERS
PREMIUM PRODUCTS
QUICK LINKS
APPS
FOLLOW
Copyright © Equitymaster Agora Research Private Limited.
Whitelist | Refer | Terms | Privacy | Contact | About | Sitemap
Equitymaster Agora Research Private Limited (Research Analyst) 103, Regent Chambers, Above Status Restaurant, Nariman Point, Mumbai - 400 021. India.
Telephone: +91-22-61434055. Fax: +91-22-22028550. Email: info@equitymaster.com. Website: www.equitymaster.com. CIN:U74999MH2007PTC175407
All rights reserved. Any act of copying, reproducing or distributing this newsletter whether wholly or in part, for any purpose without the permission of Equitymaster is strictly prohibited and shall be deemed to be copyright infringement.
LEGAL DISCLAIMER: Equitymaster Agora Research Private Limited (Research Analyst) bearing Registration No. INH000000537 (hereinafter referred as 'Equitymaster') is an independent equity research Company. Equitymaster is not an Investment Adviser. Information herein should be regarded as a resource only and should be used at one's own risk. This is not an offer to sell or solicitation to buy any securities and Equitymaster will not be liable for any losses incurred or investment(s) made or decisions taken/or not taken based on the information provided herein. Information contained herein does not constitute investment advice or a personal recommendation or take into account the particular investment objectives, financial situations, or needs of individual subscribers. Before acting on any recommendation, subscribers should consider whether it is suitable for their particular circumstances and, if necessary, seek an independent professional advice. This is not directed for access or use by anyone in a country, especially, USA, Canada or the European Union countries, where such use or access is unlawful or which may subject Equitymaster or its affiliates to any registration or licensing requirement. All content and information is provided on an 'As Is' basis by Equitymaster. Information herein is believed to be reliable but Equitymaster does not warrant its completeness or accuracy and expressly disclaims all warranties and conditions of any kind, whether express or implied. Equitymaster may hold shares in the company/ies discussed herein. As a condition to accessing Equitymaster content and website, you agree to our Terms and Conditions of Use, available here. The performance data quoted represents past performance and does not guarantee future results.
SEBI (Research Analysts) Regulations 2014, Registration No. INH000000537.